Abstract
Summary
In the course of a clinical trial of a temperature-sensitive mutant RSV vaccine, a proportion of the virus recovered exhibited genetic alteration. Some of the altered virus showed a temperature-sensitivity pattern intermediate between that of the temperature-sensitive vaccine virus and the temperature-insensitive wild type. Possible genetic mechanisms which might have produced these findings are discussed.
Get full access to this article
View all access options for this article.